The 36-month beta value for IVVD is also noteworthy at 0.87. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for IVVD is 60.29M, and at present, short sellers hold a 7.05% of that float. The average trading volume of IVVD on April 26, 2024 was 863.40K shares.
IVVD) stock’s latest price update
The stock of Invivyd Inc (NASDAQ: IVVD) has decreased by -2.82 when compared to last closing price of 2.13.Despite this, the company has seen a loss of -11.91% in its stock price over the last five trading days. InvestorPlace reported 2024-01-29 that Biotechnology companies are intriguing investment vehicles because they are part of a pretty speculative industry that allows investors to grow their investments rapidly — if they pick a company before it releases positive results. But on the flip side, a single negative press release could send a stock tumbling with biotech stocks being so volatile.
IVVD’s Market Performance
IVVD’s stock has fallen by -11.91% in the past week, with a monthly drop of -43.44% and a quarterly drop of -53.27%. The volatility ratio for the week is 7.77% while the volatility levels for the last 30 days are 9.58% for Invivyd Inc. The simple moving average for the past 20 days is -32.83% for IVVD’s stock, with a -20.14% simple moving average for the past 200 days.
Analysts’ Opinion of IVVD
Many brokerage firms have already submitted their reports for IVVD stocks, with Guggenheim repeating the rating for IVVD by listing it as a “Buy.” The predicted price for IVVD in the upcoming period, according to Guggenheim is $9 based on the research report published on April 05, 2024 of the current year 2024.
Morgan Stanley, on the other hand, stated in their research note that they expect to see IVVD reach a price target of $10, previously predicting the price at $4. The rating they have provided for IVVD stocks is “Overweight” according to the report published on March 26th, 2024.
Morgan Stanley gave a rating of “Equal-Weight” to IVVD, setting the target price at $4 in the report published on December 19th of the previous year.
IVVD Trading at -41.42% from the 50-Day Moving Average
After a stumble in the market that brought IVVD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -60.15% of loss for the given period.
Volatility was left at 9.58%, however, over the last 30 days, the volatility rate increased by 7.77%, as shares sank -48.25% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -48.25% lower at present.
During the last 5 trading sessions, IVVD fell by -11.91%, which changed the moving average for the period of 200-days by +64.29% in comparison to the 20-day moving average, which settled at $2.99. In addition, Invivyd Inc saw -47.46% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at IVVD starting from Adimab, LLC, who sale 5,000,000 shares at the price of $3.95 back on Jan 19 ’24. After this action, Adimab, LLC now owns 21,687,906 shares of Invivyd Inc, valued at $19,750,000 using the latest closing price.
Stock Fundamentals for IVVD
The total capital return value is set at -1.19. Equity return is now at value -74.48, with -64.88 for asset returns.
Based on Invivyd Inc (IVVD), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -79.98. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is 56.9.
Currently, EBITDA for the company is -205.75 million with net debt to EBITDA at 0.94. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.47.
Conclusion
In summary, Invivyd Inc (IVVD) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
